Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Eicosapentaenoic acid (EPA), a major ω-3 polyunsaturated fat...
| Class:Id | Summation:9018897 |
|---|---|
| _displayName | Eicosapentaenoic acid (EPA), a major ω-3 polyunsaturated fat... |
| _timestamp | 2018-02-21 11:35:17 |
| created | [InstanceEdit:9018893] Jassal, Bijay, 2017-09-05 |
| literatureReference | [LiteratureReference:9018721] Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both? [LiteratureReference:9020466] Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution |
| modified | [InstanceEdit:9020263] Jassal, Bijay, 2017-09-05 [InstanceEdit:9020460] Jassal, Bijay, 2017-09-06 [InstanceEdit:9020461] Jassal, Bijay, 2017-09-06 [InstanceEdit:9020476] Jassal, Bijay, 2017-09-06 [InstanceEdit:9020588] Jassal, Bijay, 2017-09-07 [InstanceEdit:9022652] Jassal, Bijay, 2017-09-25 [InstanceEdit:9023654] Jassal, Bijay, 2017-09-28 [InstanceEdit:9024014] Jassal, Bijay, 2017-09-29 [InstanceEdit:9027001] Jassal, Bijay, 2017-10-26 [InstanceEdit:9028817] Jassal, Bijay, 2017-11-10 [InstanceEdit:9037792] Jassal, Bijay, 2018-02-21 |
| text | Eicosapentaenoic acid (EPA), a major ω-3 polyunsaturated fatty acid (PUFA) found in fish oil is the source of E-series resolvins (RvEs), one of the specialized proresolving mediators (SPMs) that show potent anti-inflammatory and pro-resolving actions (Molfino et al. 2017). The biosynthesis of RvEs occurs mainly during the process of inflammation when endothelial cells interact with leukocytes. EPA, circulating in plasma or released/mobilised from damaged cellular membranes on injury or infection, moves with edema into the tissue sites of acute inflammation where it is converted to exudate RvEs to interact with local immune cells (Kasuga et al. 2008). The initial transformation of EPA by aspirin-acetylated cyclooxygenase 2- and/or cytochrome P450-mediated catalysis can produce stereospecific resolvins (18(R)- or 18(S)-RvEs). Combinations of oxidation, reduction and hydrolysis reactions determine the type of resolvin formed (RvE1, RvE2 or RvE3) (Serhan et al. 2000, 2002, Serhan & Petasis 2011, Maehre et al. 2015). |
| (summation) | [Pathway:9018679] Biosynthesis of EPA-derived SPMs [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Eicosapentaenoic acid (EPA), a major ω-3 polyunsaturated fat... (9018897)
